logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-10. Age distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (iii) All outpatient clients, age distribution by primary drug (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Mean ageAge known (base)Age not known
Hypnotics and sedatives0.46.110.513.013.613.712.929.838.2713139
Volatile substances28.030.811.
Cannabis 4.030.626.
Other substances


 The countries supplying data are: 

 AT; BE; BG; HR; CY; CZ; DK; EE; FI; FR; DE; GR; HU; IE; IT; LU; MT; NL; PL; RO; SK; SI; ES; SE; UK 

 Data for Spain refer to 2008 and to outpatient centres and treatment units in prisons. Data for Malta refer to Outpatient and specialised inpatient treatment centres, low-threshold agencies and units in prison. Data for the Netherlands refer to outpatient centres, inpatient centres and low-threshold agencies. Data for Estonia refer to outpatient and inpatient centres. Data for Poland refer to 2008 and to 33 health care units. Data for Luxembourg refer to Outpatient and Inpatient centres. 

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-103 on distribution by country and ‘General notes for interpreting data’ on the Explanatory notes and help page


 Reitox national reports 2010 — Table TDI outpatient and inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011